Shariati Hospital
Bandar Abbas, Hormozgan, 79176, Iran
NCT Number: NCT01566734
This study conducted to assess the effects of normal saline or cefazolin irrigation on the incidence of SSIs.
Hypothesis:
Normal saline or cefazolin irrigation decreases the incidence of SSIs.
Looking for future studies?
Notify MeFemale
Interventional
Not applicable
Bandar Abbas, Hormozgan, 79176, Iran
All pregnant women who underwent cesarean after 6 hours passed their rupture of membrane and attended to Shariati Hospital of Bandarabbass were eligible for our study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
after the surgery and before closing up the patients, 2 grams of cefazolin in 5 cc of distilled water was used to irrigate the patients
Other names: cephazolin, cefazoline, Ancef, Cefacidal, Cefamezin, Cefrina, Elzogram, Faxilen, Gramaxin, Kefazol, Kefol, Kefzolan, Kezolin, Novaporin, Reflin, Zinol, Zolicef
after the surgery and before closing up the patients, 150 cc of normal saline was used to irrigate the patients and in the last group
Other names: sodium chloride, saline solution
Time frame: one week after discharge
Hormozgan University of Medical Sciences
Other
Comparison of the Effect of Cefazolin and Normal Saline Irrigation With no Irrigation on the Incidence of Surgical Site Infections
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07189858
Anti-Infective Agents, Bacterial Infections
Calgary, Alberta, Canada
View Trial DetailsNCT06702878
Anti-Infective Agents, Bacterial Infections
Englewood, Colorado, United States
View Trial DetailsNCT07034573
Infections, Pathologic Processes
Bafoussam, Cameroon
View Trial DetailsNCT07104903
Colonic Diseases, Colorectal Cancer
Kamenitz, Vojvodina, Serbia
View Trial Details